Development of Pyrrole-Imidazole Polyamide for Specific Regulation of Human Aurora Kinase-A and -B Gene Expression

Chemistry and Biology

Volumn 15, Issue 8, 2008, Pages 829-841

  Takahashi, Teruyuki ^a,b   Asami, Yukihiro ^b   Kitamura, Eiko ^a   Suzuki, Tsukasa ^b   Wang, Xiaofei ^b   Igarashi, Jun ^a   Morohashi, Aiko ^a   Shinojima, Yui ^b   Kanou, Hisao ^b   Saito, Kosuke ^a   Takasu, Toshiaki ^a   Nagase, Hiroki ^a,b   Harada, Yuichi ^b   Kuroda, Kazumichi ^b   Watanabe, Takayoshi ^c   Kumamoto, Satoshi ^c   Aoyama, Takahiko ^a   Matsumoto, Yoshiaki ^a   Bando, Toshikazu ^d   Sugiyama, Hiroshi ^d   Yoshida Noro, Chikako ^a   Fukuda, Noboru ^a   Hayashi, Nariyuki ^a   more..

^a NIHON UNIVERSITY   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Gentier Biosystems Incorporation   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

CELLBIO; CHEMBIO; SIGNALING

Indexed keywords

AURORA KINASE; DNA; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; IMIDAZOLE DERIVATIVE; MESSENGER RNA; NYLON; PROTEIN SERINE THREONINE KINASE; PYRROLE DERIVATIVE;

AMINO ACID SEQUENCE; ANIMAL; APOPTOSIS; ARTICLE; CATTLE; CELL CYCLE; CELL SURVIVAL; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; ENZYME SPECIFICITY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CATTLE; CELL CYCLE; CELL SURVIVAL; DNA; DRUG DESIGN; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELA CELLS; HUMANS; IMIDAZOLES; MOLECULAR SEQUENCE DATA; NYLONS; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PYRROLES; RNA, MESSENGER; SUBSTRATE SPECIFICITY;

PIPS;

EID: 49449084047     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2008.06.006     Document Type: Article

References (25)

1. Bando T., Narita A., Saito I., and Sugiyama H. Molecular design of a pyrrole-imidazole hairpin polyamides for effective DNA alkylation. Chemistry 8 (2002) 4781-4790
2. Best T.P., Edelson B.S., Nickols N.G., and Dervan P.B. Nuclear localization of pyrrole-imidazole polyamide-fluorescein conjugates in cell culture. Proc. Natl. Acad. Sci. USA 14 (2003) 12063-12068
3. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17 (1998) 3052-3065
4. Carvajal R.D., Tse A., and Schwartz G.K. Aurora kinases: new targets for cancer therapy. Clin. Cancer Res. 12 (2006) 6869-6875
5. Chou T.C., and Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22 (1984) 27-55
6. Damaraju V.L., Bouffard D.Y., Wong C.K., Clarke M.L., Mackey J.R., Leblond L., Cass C.E., Grey M., and Gourdeau H. Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer. BMC Cancer 7 (2007) 121-131
7. Dervan P.B. Molecular recognition of DNA by small molecules. Bioorg. Med. Chem. 9 (2001) 2215-2235
8. Ditchfield C., Johnson V.L., Tighe A., Ellston R., Haworth C., Johnson T., Mortlock A., Keen N., and Taylor S.S. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol. 161 (2003) 267-280
9. Ditchfield C., Keen N., and Taylor S.S. The Ipl1/Aurora kinase family: methods of inhibition and functional analysis in mammalian cells. Methods Mol. Biol. 296 (2005) 371-381
10. Harrington E.A., Bebbington D., Moore J., Rasmussen R.K., Ajose-Adeogun A.O., Nakayama T., Graham J.A., Demur C., Hercend T., Diu-Hercend A., et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. 10 (2004) 262-267
11. Hauf S., Cole R.W., LaTerra S., Zimmer C., Schnapp G., Walter R., Heckel A., van Meel J., Rieder C.L., and Peters J.M. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 161 (2003) 281-294
12. Jung F.H., Pasquet G., Lambert-van der Brempt C., Lohmann J.J., Warin N., Renaud F., Germain H., De Savi C., Roberts N., Johnson T., et al. Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors. J. Med. Chem. 49 (2006) 955-970
13. Kanda A., Kawai H., Suto S., Kitajima S., Sato S., Takata T., and Tatsuka M. Aurora-B/AIM-1 kinase activity is involved in Ras-mediated cell transformation. Oncogene 24 (2005) 7266-7272
14. Kimura M., Uchida C., Takano Y., Kitagawa M., and Okano Y. Cell cycle-dependent regulation of the human aurora B promoter. Biochem. Biophys. Res. Commun. 316 (2004) 930-936
15. Matsuda H., Fukuda N., Ueno T., Tahira Y., Ayame H., Zhang W., Bando T., Sugiyama H., Saito S., Matsumoto K., et al. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-β1 promoter for treatment of progressive renal diseases. J. Am. Soc. Nephrol. 17 (2006) 422-432
16. Meraldi P., Honda R., and Nigg E.A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. 21 (2002) 483-492
17. Murty M.S., and Sugiyama H. Biology of N-methylpyrrole- N-methylimidazole hairpin polyamide. Biol. Pharm. Bull. 27 (2004) 468-474
18. Nickols N.G., and Dervan P.B. Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide. Proc. Natl. Acad. Sci. USA 104 (2007) 10418-10423
19. Nickols N.G., Jacobs C.S., Farkas M.E., and Dervan P.B. Improved nuclear localization of DNA-binding polyamides. Nucleic Acids Res. 35 (2007) 363-370
20. Ota T., Suto S., Katayama H., Han Z.B., Suzuki F., Maeda M., Tanino M., Terada Y., and Tatsuka M. Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. 62 (2002) 5168-5177
21. Sorrentino R., Libertini S., Pallante P.L., Troncone G., Palombini L., Bavetsias V., Spalletti-Cernia D., Laccetti P., Linardopoulos S., Chieffi P., et al. Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J. Clin. Endocrinol. Metab. 90 (2005) 928-935
22. Tanaka M., Ueda A., Kanamori H., Ideguchi H., Yang J., Kitajima S., and Ishigatsubo Y. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J. Biol. Chem. 277 (2002) 10719-10726
23. Trauger J.W., Baird E.E., and Dervan P.B. Recognition of DNA by designed ligands at subnanomolar concentrations. Nature 382 (1996) 559-561
24. Yang J., Ikezoe T., Nishioka C., Tasaka T., Taniguchi A., Kuwayama Y., Komatsu N., Bandobashi K., Togitani K., Koeffler H.P., et al. AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo. Blood 110 (2007) 2034-2040
25. Zhang W., Bando T., and Sugiyama H. Discrimination of hairpin polyamides with an alpha-substituted-gamma-aminobutyric acid as a 5′-TG-3′ reader in DNA minor groove. J. Am. Chem. Soc. 128 (2006) 8766-8776